Effect of Methanol Leaf Extract of Duranta erecta in Rats Induced with Benign Prostatic Hyperplasia doi.org/10.26538/tjnpr/v4i10.21
Main Article Content
Abstract
A common disease among elderly men is benign prostatic hyperplasia (BPH) of which oxidative stress plays important role. The present research evaluates the effect of methanol leaf extract of Duranta erecta (MLEDE) on testosterone-induced BPH in rats. The toxicity level of the extract was examined. Thirty male rats were used for the research, 5 animals served as normal control, 25 animals were induced with BPH using subcutaneous injection of testosterone for four weeks. After induction, they were grouped into five (group 2: BPH untreated, group 3 received finasteride: 3 mg/kg, group 4-6 received MEDE: 200, 400 and 600 mg/kg). Treatment lasted for three weeks. As the treatment protocol elapsed, all the animals were anesthetised. Blood were obtained via cardiac puncture for the determination of some biochemical parameters. The prostate was weighed, assayed for antioxidant activities and histologically examined. The extract was nontoxic at a dose up to 5000 mg/kg. MLEDE (at all doses) and finasteride significantly reduced the increases in prostate weight and index, serum testosterone, dihydrotestosterone, PSA and acid phosphatase caused by testosterone induction relative to the BPH rats. Testosterone induction led to increase in MDA and decreases in GSH, SOD, CAT and GPx activities that were significant but were reversed following the administration of MLEDE at all doses. The disruption of prostate histoarchitecture was improved by MLEDE. MLEDE reduced the effect of testosterone-induced BPH conceivably through enhancement of antioxidant defence system. Thus, Duranta erecta could be a promising source of herbal medicine for the management of BPH in men.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Ugwu MN, Eten MU, Omang WA, Eno MA. Effect of Vernonia amygdalina (VA) on oxidative stress status of benign prostatic hyperplasia induced-wistar rats. Asian J Res Med Pharm Sci. 2018; 4(3):1-11.
Nahata A and Dixit V. Sphaeranthus indicus attenuates testosterone induced prostatic hypertrophy in albino rats. Phyto Res J. 2011; 25:1839-1848.
Madersbachera S, Sampsonc N, Culigc Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontol. 2019; 20:1-7.
Pais P. Potency of a novel saw palmetto extract, SPET-085, for inhibition of 5alpha-reductase II. Adv Ther. 2010; 27: 555–563.
Manuj KB, and Luk, BC. Aqueous methanolicic bark extract of Oroxylum indicum inhibited testosterone induced prostate hyperplasia in rat. Phcog J. 2014; 6(3):79-85.
Shoieb SM, Amani AE, Ashraf EK, Abdel-Naim B. Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats. Food Chem Toxicol. 2018; 111:650–659.
Minciullo P, Inferrera A, Navarra M, Calapai G, Magno, C, Gangemi S. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol Int. 2015; 94:249- 254.
Hamid AR, Umbas R, Mochtar CA. Recent role of inflammation in prostate diseases: chemoprevention development opportunity. Acta Med Indones. 2011; 43:59- 65.
Ong HL, Liao CH, Kuo HC. Long-term combination therapy with α-blockers and 5α-reductase inhibitors in benign prostatic hyperplasia: patient adherence and causes of withdrawal from medication. Int Neurourol J. 2016; 20:356-362.
Ugwu CC and Anosike CA. Phytochemical screening and antioxidant potentials of methanol extract of Duranta erecta leaves. AJRB. 2020; 7(3):16-26.
Ogbuagu AS, Okoro K, Akpuaka MU, Ogbuagu JO, Ekpunobi UE, Ohaekenyem EC. Quantitative determination of some secondary metabolites and the anti - bacterial effects of the leave extracts of Duranta eracta. Am J Biomed Sci Eng. 2015; 1(5):82-87.
Puri AV. Duranta repens linn. (verbenaceae): a comprehensive review of pharmacognostic, ethnomedicinal, pharmacological, and phytochemical aspects. Asian J Pharm Clin Res. 2018; 11(11):91-96.
Agawane SB, Gupta VS, Kulkarni MJ, Bhattacharya AK, Koratkar SS and Rao VK. Patho-physiological evaluation of Duranta erecta for the treatment of urolithiasis. J Ayuveda Integr Med. 2019; 10:4-11.
Pendharkar NA, Padmalatha M, Selvan T. Antiulcer and anxiolytic effect of Durenta repens Linn in experimental animal model. Int J Pharm Sci Rev Res. 2013; 23(1):60-62.
Donkor S, Larbie C, Komlaga G, Emikpe B. Phytochemical, antimicrobial, and antioxidant profiles of Duranta erecta parts. Biochem Res Int. 2019; 20:1-11.
Lorke D. A new approach to practical acute toxicity testing. Arch Toxicol. 1983; 54:275-287.
Jang H, Ha US, Kim SJ, Yoon BI, Han DS, Yuk SM, Kim SW. Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model. J Agric Food Chem. 2010; 58(24):12686-12691.
Ishola IO, Yemitan KO, Afolayan OO, Anunobid CC, Durojaiyea TE. Potential of Moringa oleifera in the treatment of benign prostate hyperplasia: role of antioxidant defence systems. Med Prin Pract. 2017; 23:1-23.
Tietz NW, Pruden EL, Siggaard AO. Total acid phosphatase. In: Textbook of Clinical Chemistry. Burtis, A. C. and Ashwood, E. R. (Eds). London: Saunders; 1994. 1354-1374 p.
McCord J and Fridorich I. Superoxide dismutase: an enzymatic function erythrocuprein (hemocuprein). J Biol Chem. 1969; 244(22):6049-6055.
Beers RF and Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952; 195(1):133-140.
Hafemann DG, Sunde RA, hoekstra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr. 1974; 104:580-587.
Clifton NJ. Methods for determination of plasma or tissue glutathione levels. Methods Mol Biol. 2012; 889:315-324.
Devasagayam, TP, Pushpendran CK, Eapen J. Differences in lipid peroxidation of rat liver rough and smooth microsomes. Biochim Biophys Acta. 1983; 750(1):91-97.
Mbaka G, Anunobi C, Ogunsina S, Osiagwu D. Histomorphological changes in induced benign prostatic hyperplasia with exogenous testosterone and estradiol in adult male rats treated with aqueous ethanol extract of Secamone afzelii. Egypt J Basic Appl Sci. 2017; 30:1-7.
Donkor S, Larbie C, Komlaga G and Emikpe BO. Toxicity of the hydroethanolic leaves extract of Duranta erecta L. in rat models. J Parm Res Int. 2020; 32(6):9-18.
Andriole GL, Grubb RL, Buy SS. Mortality results from a randomized prostate-cancer screening trial. N Eng J Med. 2009; 360:1310-1321.
Cam K. BPH: How useful is a visual prostate symptom score for patients? Nat Rev Urol. 2011; 8: 536-537.
Griffiths K and Denis LJ. Exploitable mechanisms for the blockade of androgenic action. Prostate. 2010; 10(10):43- 51.
Cai H, Zhang G, Yan Z, Shang X. The effect of Xialiqi capsule on testosterone-induced benign prostatic hyperplasia in rats. Evid-Based Compl Altern Med. 2018; 24:1-9.
Mizokami A, Koh E, Izumi K. “Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone,” EndocrRel Cancer. 2009; 16(4):1139–1155.
Ejike CEC and Ezeanyika LUS. Management of experimental benign prostatic hyperplasia in rats using a food-based therapy containing Telfairia occidentalis seeds. Afr J Tradit Complement Altern Med. 2011; 8(4):398‐404
Jeyaraj DA, Uduyakumar TS, Rajalakshmi M, Pal PC, Sharma RS. Effects of long term administration of androgens and estrogen on Rhesus monkey prostate: possible induction of benign prostatic hyperplasia. J Androl. 2000; 21:833-841.
Chang W, Tsai Y, Wangc J, Chena H, Yangb W, Lee C. Sex hormones and oxidative stress mediated phthalateinduced effects in prostatic enlargement. Environ Int. 2019; 126:184-192.
Udensi KU and Paul BT. Oxidative stress in prostate hyperplasia and Carcinogenesis. J Exp Clin Cancer Res. 2016; 35:139-145.
Acheampong DO, Barffour IK, Boye A, Asiamah AE, Armah FA, Adokoh CK, Oluyemi JF, Adrah B, Opoku R, Adakudugu E. Histoprotective effect of essential oil from Citrus aurantifolia in testosterone-induced benign prostatic hyperplasia rat. Adv Urol. 2019; 30:1-14.